SLC7A11 and neoplasm: Mechanically, the transcription factor ETS-1 as the downstream of the MAPK signaling pathway synergized with ATF4 to directly activate SLC7A11, thus, the tumor growth in KRAS-transformed cells xenograft was inhibited upon depletion of SLC7A11 (22).